|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6207 USD | -1.87% |
|
-7.36% | -16.75% |
| Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
| Apr. 04 | Traws Pharma, Inc. Announces Chief Executive Office Changes | CI |
Onconova Therapeutics, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 0.226 million compared to USD 0.226 million a year ago. Net loss was USD 18.96 million compared to USD 16.16 million a year ago.
Basic loss per share from continuing operations was USD 0.91 compared to USD 0.96 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.75% | 13.09M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
TRAWS PHARMA, INC. 
